Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of its PTC Tempo 48/48 and PTC Tempo…
Cardinal Health (NYSE: CAH) announced today the U.S. launch of its Kangaroo OMNI™ Enteral Feeding Pump, designed to help provide enteral feeding patients with more options to meet their personalized…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review a new…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eisai today provided updates on two Phase 3 trials, LEAP-006 and LEAP-008, evaluating KEYTRUDA, Merck’s anti-PD-1…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 KEYNOTE-A39 trial (also known as EV-302), which was…
For community pharmacists, cooler temperatures, school buses on the roads and Friday night football are not just signs of a changing season – they are indicators that patients will soon…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a…
Cardinal Health (NYSE: CAH) in partnership with Children’s Hospitals Association (CHA) and the Zero Suicide Institute (ZSI) announced today the second round of grant recipients for the Preventing Youth Suicide:…
AbbVie today announced the start of its two-week public voting period for the 2023 Thriving Undergraduate and Graduate Scholarships. Following this voting period, scholarships totaling $25,000 each will be awarded to two…
At an Extraordinary General Meeting held today, Novartis shareholders approved the proposed 100% Spin-off of Sandoz, the Generics and Biosimilars business of Novartis. Shareholders also approved an ordinary capital decrease…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the European Commission (EC) has approved an expanded indication for ERVEBO for active immunization…
CVS Health® Corporation (NYSE: CVS) today announced additional responsibilities for several members of the company’s executive leadership team, effective immediately: “At a time when we are accelerating our strategy to deliver…